Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIGHT-HCM
NL-OMON58112Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in hypertrophic cardiomyopathy (HCM) and obesity, sponsored by Erasmus MC. Primary endpoint: Quality of life. Started Jan 2026; status: recruiting.
02
Conditions
hypertrophic cardiomyopathy (HCM)obesity
Beyond the preview
Go deeper on NL-OMON58112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58112.